Products
Platform
Research
Market
Learn
Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.31 | 1.88 |
NAV | ₹31.40 | ₹41.02 |
Fund Started | 20 Jun 2019 | 25 Jun 2018 |
Fund Size | ₹845.30 Cr | ₹6161.81 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.31
1.88
NAV
₹31.40
₹41.02
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹845.30 Cr
₹6161.81 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | -2.85% | 3.99% |
3 Year | 23.23% | 29.38% |
5 Year | 15.49% | 20.51% |
1 Year
-2.85%
3.99%
3 Year
23.23%
29.38%
5 Year
15.49%
20.51%
Holding Analysis
Equity | 97.86% | 95.88% |
Cash | 2.14% | 4.12% |
Equity
97.86%
95.88%
Cash
2.14%
4.12%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.96% |
Apollo Hospitals Enterprise Ltd. | 7.65% |
Cipla Ltd. | 7.09% |
Fortis Healthcare Ltd. | 5.15% |
Abbott India Ltd. | 4.82% |
Lupin Ltd. | 4.40% |
Torrent Pharmaceuticals Ltd. | 4.31% |
Ajanta Pharma Ltd. | 3.79% |
Ipca Laboratories Ltd. | 3.61% |
Anthem Biosciences Ltd. | 3.40% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Dr. Reddy's Laboratories Ltd. | 9.47% |
Divi's Laboratories Ltd. | 9.23% |
Cipla Ltd. | 7.39% |
Aurobindo Pharma Ltd. | 6.53% |
Lupin Ltd. | 5.44% |
Alkem Laboratories Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.50% |
Biocon Ltd. | 3.21% |
Gland Pharma Ltd. | 2.88% |
Fund Manager
Name | Dhaval Joshi | Dharmesh Kakkad |
Start Date | 21 Nov 2022 | 05 Feb 2020 |
Name
Dhaval Joshi
Dharmesh Kakkad
Start Date
21 Nov 2022
05 Feb 2020
About Fund
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 20 Jun 2019 | 25 Jun 2018 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018
